Diamond Biofund Inc.
VC Fund
Taipei, Taiwan
Diamond Biofund Inc. is a VC fund in Taipei focused on Health Care and Biotechnology. Diamond BioFund is a company that provides funds in life science sector, dedicated to biotechnology innovation.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Diamond Biofund Inc. invests in
Stages Diamond Biofund Inc. invests in
Countries Diamond Biofund Inc. invests in
Investment Focus
Industry
- Health Care 6 (86%)
- Biotechnology 5 (71%)
- Medical 2 (29%)
- Genetics 1 (14%)
- Consulting 1 (14%)
Stage
- Seed 2 (29%)
- Venture - Series Unknown 2 (29%)
- Series B 1 (14%)
- Series C 1 (14%)
- Corporate Round 1 (14%)
Country
- United States 4 (57%)
- Taiwan 2 (29%)
- Israel 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rejuvenate Bio
|
Rejuvenate Bio is a biotechnology company that develops novel gene therapies for dogs. The company's therapy provides a solution for the mitral valve disease to stop the progression of heart failure in dogs, thus providing pets with extended overall health and maximal lifespan. It was founded in 2017 and is based in San Diego, CA. | Venture - Series Unknown / Jul 01, 2024 | |
StemCyte
|
StemCyte, Inc. operates as an umbilical cord blood stem cell transplantation and therapeutic products company. It provides cord blood products to transplant centers for life-threatening diseases. The company's products are used to treat patients suffering from various blood cancers, and immune and genetic disorders. StemCyte, Inc. was foundedin 1997 and is headquartered in Covina, California. It operates umbilical cord blood storage facilities in California and Taiwan. The company has locations in the United States, India, and Taiwan. | $6.4M / Venture - Series Unknown / Nov 08, 2023 | |
ImmunAdd
|
ImmunAdd is a biotech startup developing fully synthetic saponin-based vaccine adjuvants. | Seed / Jan 01, 2023 | |
Bilayer Therapeutics
|
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts. | Seed / Jan 01, 2022 | |
EyeYon
|
EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator. | $25M / Series C / Mar 15, 2021 | |
Ativa Medical
|
Ativa Medical is a medical device manufacturing company that is working to make diagnostic test results available in moments, rather than hours and days. The company specializes in the fields of medical device development, point of care diagnostics, microfluidics, and hematology.The company was founded in 2008 and headquartered in Saint Paul,Minnesota. | $15M / Series B / Sep 17, 2015 | |
Tetanti Agribiotech Inc.
|
Dr. Young holds a PhD degree in agronomy and soil science awarded by University of Hawaii. He is the pioneer in the field of organic fertilizer and soil microorganisms in Taiwan and was awarded the Academician honor in 2016.TTT® technology is the world’s only destructive and innovative concept that revolutionizes the traditional microbialcomposting process with the use of enzymes to stabilize and mature organic wastes. It raises the maturing efficiency more than 100-fold, and our zero pollution composting technology is able to avoid bad smell and waste water produced during the process.Dr. Young has profound influence on the industry in Taiwan and will lead our business to expand internationally as well as establish our group at the top of circular economy.•Broad microorganism and enzyme database：We possess more than 7,000 bacterial isolates that can provide functional and optimized enzyme formulations for different composting materials. •Professional know-how service：The rapid composting technology is a combination of microbiology, biochemistry, soil science, physics, as well as long term practical experiences. It can provide all-around total solution services for any organic wastes. •No more NIMBY protests：Rapid composting technology is pollution-free and can resolve the protests from the neighborhood. | Corporate Round |
Co-Investors
Fubon Financial Holdings
1 deal together
Global health sciences venture fund
1 deal together
Harvest Heaven
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Diamond Biofund Inc. invest in?
Diamond Biofund Inc. invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Venture - Series Unknown stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Diamond Biofund Inc. last invest?
The most recent investment recorded for Diamond Biofund Inc. closed in Jul 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
